Showing results (1571-1580 of 2,171) with videos related to
Sort By:
Pageof 218
Dermatitis : Contact, Atopic, Occupational, Drug|February 6, 2026
Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based StudyAbigail Katz, Yvonne Nong, Elaine J Ma, et al.Dermatology and Therapy|October 6, 2023
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-AnalysisApril W Armstrong, Richard B Warren, Yichen Zhong, et al.The Canadian Journal of Cardiology|April 5, 2003
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromesFadi H Khadour, Yuling Fu, Wei-Ching Chang, et al.American Heart Journal|April 9, 2011
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline riskRajendra H Mehta, Aijing Z Starr, Renato D Lopes, et al.Journal of Chromatography. A|February 6, 2018
Macrocyclic glycopeptide chiral selectors bonded to core-shell particles enables enantiopurity analysis of the entire verubecestat synthetic routeChandan L Barhate, Diego A Lopez, Alexey A Makarov, et al.Journal of Proteome Research|June 12, 2026
Proteomic Insights into Intrauterine Growth Restriction and Its Role in Asthma PathogenesisYichen Lv, Katherine Huang, Natalie Thomas, et al.Journal of the American Heart Association|March 23, 2019
Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Claes Held, Sue Krug-Gourley, et al.The Canadian Journal of Cardiology|June 23, 2026
Impact of Baseline Q Waves and Reperfusion Strategy on Outcomes in ST-elevation Myocardial Infarction: Insights from the Vital Heart Response RegistryRobert T Kay, Josh Perka, Ajay Sidhu, et al.European Journal of Heart Failure|December 13, 2000
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study GroupM J Sculpher, L Poole, J Cleland, et al.Journal of the National Cancer Institute|September 16, 1992
Environmental tobacco smoke and lung cancer risk in nonsmoking womenH G Stockwell, A L Goldman, G H Lyman, et al.Pageof 218